{"url_path":"/sec/mirm/8-k/2026-05-18/item-2-03","section_key":"item-2-03","section_title":"Item 2.03 Creation of a Direct Financial Obligation or an Off-Balance Sheet Arrangement.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1759425/0001193125-26-228902-index.html","accession_number":"0001193125-26-228902","cik":"0001759425","ticker":"MIRM","issuer_name":"Mirum Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1759425/0001193125-26-228902-index.html","primary_entity_key":"0001759425","primary_entity_name":"Mirum Pharmaceuticals, Inc."},"word_count":29,"has_tables":true,"body_markdown":"Item 2.03\n\nCreation of a Direct Financial Obligation or an Off-Balance Sheet Arrangement.\n\nThe disclosure set forth in Item 1.01 above is incorporated by reference into this Item 2.03."}